Weight loss and Psoriasis


Psoriasis is found among people with Weight loss, especially for people who are male, 50-59 old.

The study analyzes which people have Psoriasis with Weight loss. It is created by eHealthMe based on reports of 18 people who have Weight loss from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Dec, 01, 2022

18 people who have Weight Loss and Psoriasis are studied.

What is Weight loss?

Weight loss is found to be associated with 2,689 drugs and 2,163 conditions by eHealthMe.

What is Psoriasis?

Psoriasis (immune-mediated disease that affects the skin) is found to be associated with 2,258 drugs and 1,579 conditions by eHealthMe.

Number of Psoriasis in Weight loss reports submitted per year:

Would you have Psoriasis when you have Weight loss?

Gender of people who have Weight Loss and experienced Psoriasis *:

  • female: 47.06 %
  • male: 52.94 %

Age of people who have Weight Loss and experienced Psoriasis *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 8.33 %
  • 30-39: 25.0 %
  • 40-49: 25.0 %
  • 50-59: 25.0 %
  • 60+: 16.67 %

Common co-existing conditions for these people *:

  1. High Blood Cholesterol: 6 people, 33.33%
  2. Abdominal Discomfort: 5 people, 27.78%
  3. Infarction (obstruction of the blood supply to an organ or region of tissue): 3 people, 16.67%
  4. High Blood Pressure: 3 people, 16.67%
  5. Type 2 Diabetes: 1 person, 5.56%
  6. Rhinitis (a medical term for irritation and inflammation of the mucous membrane inside the nose): 1 person, 5.56%
  7. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 5.56%
  8. Osteoporosis (bones weak and more likely to break): 1 person, 5.56%
  9. Migraine (headache): 1 person, 5.56%
  10. Metabolic Syndrome (a combination of the medical disorders that, when occurring together, increase the risk of developing cardiovascular disease): 1 person, 5.56%

Common drugs taken by these people *:

  1. Xenical: 7 people, 38.89%
  2. Lipitor: 5 people, 27.78%
  3. Plavix: 4 people, 22.22%
  4. Pantoprazole Sodium: 3 people, 16.67%
  5. Humira: 2 people, 11.11%
  6. Tramadol: 2 people, 11.11%
  7. Meridia: 2 people, 11.11%
  8. Paracetamol: 2 people, 11.11%
  9. Diabeta: 1 person, 5.56%
  10. Fosamax: 1 person, 5.56%

Common symptoms for these people *:

  1. Stress And Anxiety: 7 people, 38.89%
  2. Balance Disorder: 6 people, 33.33%
  3. Depression: 6 people, 33.33%
  4. Muscle Aches (muscle pain): 6 people, 33.33%
  5. Pain In Extremity: 5 people, 27.78%
  6. Vertigo Positional: 5 people, 27.78%
  7. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder): 5 people, 27.78%
  8. Cardiac Disorder: 5 people, 27.78%
  9. Fall: 5 people, 27.78%
  10. Gait Disturbance: 5 people, 27.78%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Psoriasis?

Check whether Psoriasis is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Psoriasis:

Common drugs associated with Psoriasis:

All the drugs that are associated with Psoriasis:

Common conditions associated with Psoriasis:

All the conditions that are associated with Psoriasis:

How the study uses the data?

The study is based on Psoriasis and Weight loss, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: